Bone-marrow cells in therapy of critical limb ischaemia of lower extremities - Own experience;Komórki macierzyste w terapii krytycznego niedokrwienia - Doświadczenia własne

Acta Angiologica

Volumn 12, Issue 4, 2006, Pages 155-166

  Barć, Piotr ^a   Skóra, Jan ^a   Pupka, Artur ^a   Turkiewicz, Dominik ^a   Dorobisz, Andrzej T ^a   Garcarek, Jerzy ^a   Tomasiewicz, Beata ^a   Szyber, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Critical limb ischaemia; Endothelial progenitor cells (EPC); Stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1;

AMPUTATION; ARTERIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BONE MARROW BIOPSY; BONE MARROW CELL; CELL THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMPLANTATION; LIMB ISCHEMIA; TECHNIQUE; TREATMENT OUTCOME;

EID: 33947320327     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Reyes M, Dudek A, Jahagirdar B et al (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest, 109: 337-346.
2. Simper D, Stalboerger PG, Panetta CJ et al (2002) Smooth muscle progenitor cells in human blood. Circulation, 106: 1199-1204.
3. Shintani S, Murohara T, Ikeda H et al (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103: 2776-2779.
4. Iwakura A, Luedemann C, Shastry S et al (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation, 108: 3115-3121.
5. Hattori K, Heissig B, Tashiro K et al (2001) Plasma elevation of stromal cell-derived factor I induces mobilization of mature and immature hematopoetic progenitor and stem cells. Blood, 97: 3354-3360.
6. Peichev M, Naiyer AJ, Pereira D et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood, 95: 952-958.
7. Yamaguchi J, Kusano KF, Masuo O et al (2003) Stromal cell-derived factor I effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 107: 1322-1328.
8. Schober A, Knarren S, Lietz M et al (2003) Crucial role of stromal cell-derived factor I in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation, 108:r108-r114.
9. Takahashi T, Kearney M, Magner M et al (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 4: 434-438.
10. Hill JM, Zalos G, Halcox JPJ et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 348: 593-600.
11. Vasa M, Fichtlscherer S, Aicher A et al (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 89: e1-e7.
12. Biegus J, Skóra J, Rybak Z (2005) Angiogeneza w chorobach naczyń. Flebologia, 13: 233-239.
13. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry International Society of Hematothe-rapy and Graft Engineering. J Hematother, 5: 213-226.
14. Higashi Y, Kimura M, Hara K et al (2004) Autogenous bone marrow mononuclear cell implantation improves endothelium-depend vasodilatation in patients with limb ischemia. Circulation, 109: 12151-218.
15. Takeishi-Yuyama E, Matsubara H, Murohara T et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet, 360: 427-435.
16. Griese DP, Ehsan A, Melo LG et al (2003) Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts. Circulation, 108: 2710-2715.